1. Acknowledgement to Referees

   ACKNOWLEDGEMENT TO REFEREES 30 November 2018 Pages: 1857 - 1860

2. Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A

   • Paul Knöbl

   Therapy in Practice Open access 12 December 2018 Pages: 1861 - 1872

   

3. Current and Future Treatment Options for Myelodysplastic Syndromes: More Than Hypomethylating Agents and Lenalidomide?

   • Katja Sockel
   • Uwe Platzbecker

   Review Article 22 November 2018 Pages: 1873 - 1885

   

4. Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review

   • Y. E. Lentferink
   • C. A. J. Knibbe
   • M. M. J. van der Vorst

   Systematic Review 03 December 2018 Pages: 1887 - 1901

   

5. Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

   • Hannah A. Blair

   Adis Drug Evaluation Open access 03 December 2018 Pages: 1903 - 1910

6. Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

   • Hannah A. Blair

   Correction Open access 12 December 2018 Pages: 1911 - 1911

7. Enzalutamide: A Review in Castration-Resistant Prostate Cancer

   • Lesley J. Scott

   Adis Drug Evaluation 08 December 2018 Pages: 1913 - 1924

8. Omidenepag Isopropyl Ophthalmic Solution 0.002%: First Global Approval

   • Sean Duggan

   AdisInsight Report 21 November 2018 Pages: 1925 - 1929

   

9. Omadacycline: First Global Approval

   • Anthony Markham
   • Susan J. Keam

   AdisInsight Report 23 November 2018 Pages: 1931 - 1937

   

10. Talazoparib: First Global Approval

    • Sheridan M. Hoy

    AdisInsight Report 30 November 2018 Pages: 1939 - 1946

    

11. Dacomitinib: First Global Approval

    • Matt Shirley

    AdisInsight Report 30 November 2018 Pages: 1947 - 1953

    

12. Correction to: Caplacizumab: First Global Approval

    • Sean Duggan

    Correction Open access 03 December 2018 Pages: 1955 - 1955